<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Behav Brain Funct</journal-id><journal-title>Behavioral and Brain Functions : BBF</journal-title><issn pub-type="epub">1744-9081</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1744-9081-5-8</article-id><article-id pub-id-type="pmid">19228412</article-id><article-id pub-id-type="doi">10.1186/1744-9081-5-8</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Attention Deficit Hyperactivity Disorder comorbid oppositional defiant disorder and its predominately inattentive type: evidence for an association with COMT but not MAOA in a Chinese sample</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Qian</surname><given-names>Qiu-Jin</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>qiujinqian@hotmail.com</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Liu</surname><given-names>Jin</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>liujin_65@263.net</email></contrib><contrib id="A3" corresp="yes" contrib-type="author"><name><surname>Wang</surname><given-names>Yu-Feng</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>wangyf@bjmu.edu.cn</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Yang</surname><given-names>Li</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>lyangli375@sohu.com</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Guan</surname><given-names>Li-Li</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>lili.g@163.com</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Faraone</surname><given-names>Stephen V</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>faraones@upstate.edu</email></contrib></contrib-group><aff id="I1"><label>1</label>Institute of Mental Health, Peking University, Beijing, 10083, China </aff><aff id="I2"><label>2</label>Key Laboratory of Mental Health, Ministry of Health, Peking University, Beijing, 10083, China</aff><aff id="I3"><label>3</label>Departments of Psychiatry and Neuroscience &#x00026; Physiology, SUNY Upstate Medical University, Syracuse, New York, USA</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>19</day><month>2</month><year>2009</year></pub-date><volume>5</volume><fpage>8</fpage><lpage>8</lpage><ext-link ext-link-type="uri" xlink:href="http://www.behavioralandbrainfunctions.com/content/5/1/8"/><history><date date-type="received"><day>4</day><month>9</month><year>2008</year></date><date date-type="accepted"><day>19</day><month>2</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Qian et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Qian et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Qian Qiu-Jin qiujinqian@hotmail.com </dc:author><dc:title> Attention Deficit Hyperactivity Disorder comorbid oppositional defiant disorder and its predominately inattentive type: evidence for an association with COMT but not MAOA in a Chinese sample </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>Behavioral and Brain Functions 5(1): 8-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1744-9081(2009)5:1&#x0003c;8&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1744-9081</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>There are three childhood disruptive behavior disorders (DBDs), attention deficit hyperactivity disorder (ADHD), oppositional defiant disorder (ODD), and conduct disorder (CD). The most common comorbid disorder in ADHD is ODD. DSM-IV describes three ADHD subtypes: predominantly inattentive type (ADHD-IA), predominantly hyperactive-impulsive type (ADHD-HI), and combined type (ADHD-C). Prior work suggests that specific candidate genes are associated with specific subtypes of ADHD in China. Our previous association studies between ADHD and functional polymorphisms of COMT and MAOA, consistently showed the low transcriptional activity alleles were preferentially transmitted to ADHD-IA boys. Thus, the goal of the present study is to test the hypothesis that COMT Val158Met and MAOA-uVNTR jointly contribute to the ODD phenotype among Chinese ADHD boys.</p></sec><sec sec-type="methods"><title>Methods</title><p>171 Chinese boys between 6 and 17.5 years old (mean = 10.3, SD = 2.6) with complete COMT val158met and MAOA-uVNTR genotyping information were studied. We used logistic regression with genotypes as independent variables and the binary phenotype as the dependent variable. We used p &#x0003c; 0.05 as the level of nominal statistical significance. Bonferroni correction procedures were used to adjust for multiple comparisons.</p></sec><sec><title>Results</title><p>Our results highlight the potential etiologic role of COMT in the ADHD with comorbid ODD and its predominately inattentive type in male Chinese subjects. ADHD with comorbid ODD was associated with homozygosity of the high-activity Val allele, while the predominantly inattentive ADHD subtype was associated with the low-activity Met allele. We found no evidence of association between the MAOA-uVNTR variant and ADHD with comorbid ODD or the ADHD-IA subtype.</p></sec><sec><title>Conclusion</title><p>Our study of attention deficit hyperactivity disorder comorbid oppositional defiant disorder and its predominately inattentive type highlights the potential etiologic role of COMT for ADHD children in China. But we failed to observe an interaction between COMT and MAOA, which suggests that epistasis between COMT and MAOA genes does not influence the phenotype of ADHD-IA with comorbid ODD in a clinical sample of Chinese male subjects. To confirm our findings further studies with a larger number of subjects and healthy controls are needed.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>The three childhood disruptive behavior disorders (DBDs), attention deficit hyperactivity disorder (ADHD), oppositional defiant disorder (ODD), and conduct disorder (CD), are characterized by developmentally extreme and impairing levels of distractibility, hyperactivity, impulsivity, hostility, and aggression [<xref ref-type="bibr" rid="B1">1</xref>]. They account for a significant number of child psychiatry referrals [<xref ref-type="bibr" rid="B2">2</xref>]. The most common comorbid disorder in ADHD is ODD, with our prior work reporting that 36.5% of children with ADHD have ODD in a sample of Chinese outpatients [<xref ref-type="bibr" rid="B3">3</xref>].</p><p>DSM-IV for ADHD describes three subtypes: predominantly inattentive type (ADHD-IA), predominantly hyperactive-impulsive type (ADHD-HI), and combined type (ADHD-C), each with different characteristics and correlates [<xref ref-type="bibr" rid="B1">1</xref>]. Although ADHD is characterized by core symptoms (inattention, hyperactivity and impulsivity), there is considerable heterogeneity in clinical features among individuals with ADHD [<xref ref-type="bibr" rid="B4">4</xref>]. Some twin studies have demonstrated that the transmission of inattentive and hyperactive-impulsive symptoms is distinct [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B6">6</xref>]. With a heritability estimate of 0.76 [<xref ref-type="bibr" rid="B7">7</xref>], evidence that the etiology of ADHD is partially due to genes is compelling. The evidence that there may be genes associated with specific ADHD subtypes [<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B8">8</xref>] supported the heterogeneity inherent in the definition of ADHD. Research has found that specific candidate genes are associated with specific subtypes of ADHD in China. In our prior work, the Met allele of COMT was over transmitted to ADHD boys, especially the ADHD-IA subtype, and the -697G allele and haplotype -759C/-697G of HTR2C was significantly over transmitted to ADHD-C probands [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>].</p><p>Because there is evidence that the covariation between ADHD, ODD, and CD is largely due to shared genetic influences [<xref ref-type="bibr" rid="B12">12</xref>,<xref ref-type="bibr" rid="B13">13</xref>], it is likely that at least some genes are related to general susceptibility to DBDs [<xref ref-type="bibr" rid="B13">13</xref>], and that dopaminergic genes may influence all of the externalizing disorders.</p><p>Monoamine neurotransmitters in the brain, including dopamine (DA), noradrenalin (NE), and serotonin (5-HT), are metabolized by two key enzymes, catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO). These two enzymes are of interest in the study of aggressive behavior in both animals and human subjects.</p><p>The human COMT gene on 22q11 contains a functional polymorphism (Val158Met) affecting the activity of the enzyme at body temperature [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. The low-activity Met allele results in slower inactivation of extracellular dopamine within the brain, especially in prefrontal cortex [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>]. There are data showing gender-specific effects of COMT Val158Met genetic polymorphism on measures of cognitive function [<xref ref-type="bibr" rid="B17">17</xref>]. We have previously reported the low enzyme activity COMT Met allele was preferentially transmitted to ADHD boys but not girls [<xref ref-type="bibr" rid="B9">9</xref>]. Early-onset antisocial behavior in a high risk clinical group is predicted by COMT Val158Met and birth weight, in which children with the ValVal genotype were more susceptible to the effects of lower birth weight, had more symptoms of conduct disorder and more aggressive behaviors compared with Met carriers [<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B19">19</xref>], although one study gave negative results [<xref ref-type="bibr" rid="B20">20</xref>].</p><p>The gene for monoamine oxidase A (MAOA) maps to Xp11.23. The longer repeats (3.5R, 4R, and 5R) of a functional polymorphism in the promoter region of the MAOA gene consists of 30-bp upstream repeats (MAOA-uVNTR). The long alleles have been shown to affect the transcription of the gene three to four times more efficiently than the shorter 3R allele [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>]. Studies in both humans and animal models have supported the involvement of MAOA in the etiology of externalizing behaviors, especially in males, including impulsivity and aggression [<xref ref-type="bibr" rid="B23">23</xref>-<xref ref-type="bibr" rid="B26">26</xref>], and ADHD [<xref ref-type="bibr" rid="B27">27</xref>]. In our research group, Zhang et al., found a significant preferential transmission of the 3R allele of MAOA-uVNTR to ADHD among boys (<italic>P </italic>= 0.01), and also the inattentive subtype of ADHD in boys (<italic>P </italic>= 0.02). Zhang et al. found no association between MAOA-uVNTR and ADHD among boys comorbid with ODD.</p><p>Since our previous association studies between ADHD clinical phenotypes and these two functional polymorphisms consistently showed the low transcriptional activity alleles were preferentially transmitted to the inattentive subtype of ADHD in boys, and because these polymorphisms are all involved in the probable etiology of externalizing behaviors, the goal of the present study is to test the hypothesis that COMT Val158Met and MAOA-uVNTR jointly contribute to the phenotype of ADHD-IA with comorbid oppositional defiant disorder (ODD) in a clinical sample of Chinese male subjects.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Subjects</title><p>ADHD cases were recruited from the child psychiatric clinics at Peking University Institute of Mental Health. Those families who gave consent to participate in the study underwent the assessment process. The study was approved by the Ethics Committee of the Health Science Center, Peking University. To be included in the study, children had to meet three criteria: (1) meet Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria for ADHD[<xref ref-type="bibr" rid="B1">1</xref>], (2) have a full scale IQ above 85 according to the Wechsler Intelligence Scale for Chinese Children [<xref ref-type="bibr" rid="B28">28</xref>], and (3) be from the male Han population. The exclusion criteria were: cases with any evidence of major neurological conditions or a primary diagnosis of schizophrenia, affective disorder, pervasive development disorder, or epilepsy.</p></sec><sec><title>Assessments</title><p>Consensus diagnoses were made according to the Clinical Diagnostic Interviewing Scale (CDIS) [<xref ref-type="bibr" rid="B29">29</xref>], a structured interview based on the DSM-IV. The CDIS assesses behavioral and emotional disorders during childhood, including ADHD. The CDIS was translated into Chinese by our group. This rating scale has good sensitivity (97.2%) and specificity (100%) for ADHD. The test-retest reliability and criterion validity were each 0.89. The inter-rater reliability kappa coefficient was 0.74 (P &#x0003c; 0.01) [<xref ref-type="bibr" rid="B3">3</xref>]. The CDIS assesses the three DSM-IV subtypes of ADHD: ADHD inattentive type (ADHD-IA), ADHD hyperactive-impulsive type (ADHD-HI), and ADHD combined type (ADHD-C). All the parents were interviewed by two psychiatrists separately, including one senior psychiatrist. Teachers completed Rutter's Scale to evaluate the children's behaviors. Finally, consensus diagnoses were assigned to all probands.</p><p>The intelligence quotient (IQ) of subjects was assessed using the Chinese-Wechsler Intelligence Scale for Children (C-WISC), a revised edition of the Wechsler Intelligence Scale for Children-Revised (WISC-R), which was standardized by Gong and Cai [<xref ref-type="bibr" rid="B28">28</xref>].</p></sec><sec><title>Genotyping</title><p>Genomic DNA was extracted from whole venous blood using the protein-depositing method. The COMT val158met (rs4680) was genotyped under conditions previously described [<xref ref-type="bibr" rid="B9">9</xref>]. The MAOA-uVNTR was genotyped according to the protocols described previously [<xref ref-type="bibr" rid="B21">21</xref>]. Ambiguous or unidentifiable results were reamplified and rescored. Samples that continued to amplify poorly were eliminated from the study. All genotyping was blinded to the subject's ADHD status and IQ score and all clinical assessments were blinded to genotype status.</p></sec><sec><title>Statistics</title><p>We used logistic regression with genotypes as independent variables and the binary phenotype as the dependent variable. We used p &#x0003c; 0.05 as the level of nominal statistical significance. Bonferroni correction procedures were used to adjust for multiple comparisons.</p></sec></sec><sec><title>Results</title><p>There were 171 Chinese boys between 6 and 17.5 years old (mean = 10.3, SD = 2.6) with complete COMT val158met and MAOA-uVNTR genotyping information. ADHD-IA accounted for 53.2% of the sample, ADHD-C 39.8%, and ADHD-HI 7.0%. Many ADHD children also met diagnostic criteria for other disorders: 32.7% had comorbid ODD, 6.4% had comorbid CD, 13.4% had an emotional disorder, 13.5% had a tic disorder, 10.5% had an affective disorder, and 32.2% had a learning disability (LD).</p><sec><title>Frequency of allele and genotype</title><p>For the COMT Val158Met polymorphism, 171 ADHD boys were successfully genotyped. The allele frequencies were: Val allele 66.1%, Met 33.9%. The genotype frequencies were: valval 42.7%, ValMet 46.8%, MetMet 10.5%. For the MAOA-uVNTR, 185 ADHD boys were successfully genotyped. The 1, 2 and 5 R alleles of MAOA-uVNTR were rare. Therefore, four individuals who carried them (one boy had the 1R allele, two boys had the 2R allele, and one boy had the 5R allele) were excluded. Since the MAOA gene is X-linked, males had only one allele. The alleles were grouped as 3R and 4R in the males for statistical analyses. The allele frequencies were: 3R allele 69.6%, 4R 30.4%. The genotype distributions of the COMT and MAOA gene polymorphism were in Hardy-Weinberg equilibrium (<italic>P </italic>&#x0003e; 0.05). The numbers of subjects in each group are showed in table <xref ref-type="table" rid="T1">1</xref>.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>The numbers of subjects in each category of ADHD</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">ADHD subtype</td><td align="left">with ODD</td><td align="right">without ODD</td><td align="right">total</td></tr></thead><tbody><tr><td align="left">ADHD -IA</td><td align="left">20 (22.0%)</td><td align="right">71 (78.0%)</td><td align="right">91</td></tr><tr><td align="left">ADHD -C, adhd-HI</td><td align="left">36 (45.0%)</td><td align="right">44 (55.0%)</td><td align="right">80</td></tr><tr><td colspan="4"><hr></hr></td></tr><tr><td align="left">total</td><td align="left">56</td><td align="right">115</td><td align="right">171</td></tr></tbody></table></table-wrap></sec><sec><title>Association between COMT and ODD in ADHD Children</title><p>Based on the val158met genotypes, subjects were divided into groups: 73 homozygous for the Val allele and 98 carriers of Met allele since the frequency of the metmet genotype was rare. In the comparison of ADHD with and without ODD, the valval genotype was more frequent among children with ADHD and ODD compared with those having ADHD only (x<sup>2 </sup>= 5.46. p = 0.019). No statistically significant group differences were found for MAOA-uVNTR (Table <xref ref-type="table" rid="T2">2</xref>).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>genotype frequency of COMT and MAOA between two phenotypes</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td></td><td align="center">ADHD with ODD (n = 56)</td><td align="center">ADHD without ODD (n = 115)</td><td align="center">X<sup>2</sup></td><td align="center"><italic>P</italic></td></tr></thead><tbody><tr><td align="left">COMT</td><td align="left">ValVal</td><td align="center">31 (55.4%)</td><td align="center">42 (36.5%)</td><td></td><td></td></tr><tr><td></td><td align="left">ValMet/MetMet</td><td align="center">25 (44.6%)</td><td align="center">73 (63.5%)</td><td align="center">5.461</td><td align="center">0.019</td></tr><tr><td align="left">MAOA</td><td align="left">3R</td><td align="center">38 (67.9%)</td><td align="center">81 (70.4%)</td><td></td><td></td></tr><tr><td></td><td align="left">4R</td><td align="center">18 (32.1%)</td><td align="center">34 (29.6%)</td><td align="center">0.118</td><td align="center">0.731</td></tr></tbody></table></table-wrap></sec><sec><title>Gene-gene interaction between COMT and MAOA on ADHD phenotype</title><p>Logistic regression was used to assess the joint effects of the COMT and MAOA genes on the risk for ODD. Table <xref ref-type="table" rid="T3">3</xref> shows that the effect of COMT Val158Met was significant after partialing out the effects of MAOA-uVNTR (p = 0.021). The valval genotype increased the risk for ODD 2.2 (1/0.465) times more than the valmet/metmet genotypes. The interaction effect was not significant. The effect of COMT was significant when correcting for the two tests of main effects (p = 0.042), but not when including the interaction effect.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Logistic regression analysis of ADHD with and without ODD subtype</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">&#x003b2;</td><td align="center">S.E.</td><td align="center">Wald Test</td><td align="center"><italic>P</italic></td><td align="center">OR</td></tr></thead><tbody><tr><td align="center">MAOA-uVNTR</td><td align="center">0.109</td><td align="center">0.357</td><td align="center">0.090</td><td align="center">0.764</td><td align="center">1.113</td></tr><tr><td align="center">COMT Val158Met</td><td align="center">-0.766</td><td align="center">0.331</td><td align="center">5.345</td><td align="center">0.021</td><td align="center">0.465</td></tr><tr><td align="center">Interaction</td><td align="center">-0.006</td><td align="center">0.724</td><td align="center">0.000</td><td align="center">0.994</td><td align="center">0.994</td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="center">constant</td><td align="center">0.875</td><td align="center">1.255</td><td align="center">---</td><td align="center">---</td><td align="center">---</td></tr></tbody></table></table-wrap><p>Our previous study showed that COMT met allele and MAOA 3R allele were preferentially transmitted to ADHD boys but not girls, especially the ADHD-IA subtype. In this study, binary logistic regression was used to assess the cumulative and interactive effects of the COMT and MAOA genes on the risk for ADHD subtypes. The dependent factor was the ADHD phenotype with 1 = non ADHD-IA subtype and 2 = ADHD-IA subtype, and the covariates were the genotypes of COMT and MAOA. When comparing the ADHD-IA cases with non ADHD-IA cases, Tables <xref ref-type="table" rid="T4">4</xref> shows that the effects of the COMT risk genotype were significant after partialing out the effects of the MAOA genotype (p = 0.025). The valmet/metmet genotype affected the ADHD-IA subtype 2.024 times more profoundly than the valval genotype. There remained a statistically significant difference when it was adjusted with Bonferroni method (p = 0.050).</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Logistic regression analysis of ADHD-I and non ADHD-I subtype</p></caption><table frame="hsides" rules="groups"><thead><tr><td></td><td align="center">&#x003b2;</td><td align="center">S.E.</td><td align="center">Wald Test</td><td align="center"><italic>P</italic></td><td align="center">OR</td></tr></thead><tbody><tr><td align="center">MAOA-uVNTR</td><td align="center">0.019</td><td align="center">0.339</td><td align="center">0.003</td><td align="center">0.956</td><td align="center">1.019</td></tr><tr><td align="center">COMT Val158Met</td><td align="center">0.705</td><td align="center">0.314</td><td align="center">5.037</td><td align="center">0.025</td><td align="center">2.024</td></tr><tr><td align="center">Interaction</td><td align="center">-0.902</td><td align="center">0.679</td><td align="center">1.767</td><td align="center">0.184</td><td align="center">0.406</td></tr><tr><td colspan="6"><hr></hr></td></tr><tr><td align="center">constant</td><td align="center">-1.015</td><td align="center">1.242</td><td align="center">---</td><td align="center">---</td><td align="center">---</td></tr></tbody></table></table-wrap></sec></sec><sec><title>Discussion</title><p>Our results highlight the potential etiologic role of COMT in the ADHD comorbid ODD and its predominately inattentive type in male Chinese subjects. ADHD with comorbid ODD was associated with homozygosity of the high-activity Val allele, while the predominantly inattentive ADHD subtype was associated with the low-activity Met allele.</p><p>Catechol-<italic>O</italic>-methyltransferase methylates released catecholamines, including dopamine, as part of the catabolic cascade of this neurotransmitter to homovanillic acid. Two main COMT protein isoforms exist, the short, soluble cytoplasmic (S-COMT) isoform predominates in most assayed tissues [<xref ref-type="bibr" rid="B30">30</xref>], while a longer membrane bound form (MB-COMT) is the major species in brain [<xref ref-type="bibr" rid="B31">31</xref>]. Although expressed widely, COMT appears to be a minor player in dopamine clearance compared with neuronal synaptic uptake by the dopamine transporter and subsequent monoamine oxidase (MAO) metabolism [<xref ref-type="bibr" rid="B32">32</xref>]. However, studies in rats, knockout mice, and monkeys suggest that COMT is of particular importance for intrasynaptic dopamine regulation in the prefrontal cortex (PFC) [<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B36">36</xref>,<xref ref-type="bibr" rid="B15">15</xref>], where dopamine transporter expression is low [<xref ref-type="bibr" rid="B35">35</xref>]. Mesocortical dopamine inputs to the prefrontal cortex play a critical role in normal cognitive processes, behavior, and motivation [<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. There appears to be excessive transmission of the allele that produces more COMT activity and less PFC DA in some psychiatric disorders, which would cause less efficient PFC processing. [<xref ref-type="bibr" rid="B39">39</xref>-<xref ref-type="bibr" rid="B42">42</xref>]. There were data that indicated an effect of the COMT Val158Met genetic polymorphism on cognitive functions in childhood [<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B17">17</xref>], which showed gender-specific effects on measures of IQ and executive function [<xref ref-type="bibr" rid="B17">17</xref>]. ADHD children who were homozygous for the valine variant had significantly better sustained attention than those ADHD children possessing at least one copy of the methionine variant [<xref ref-type="bibr" rid="B44">44</xref>].</p><p>The PFC has also been implicated in the etiology of aggressive and antisocial behavior in children [<xref ref-type="bibr" rid="B45">45</xref>]. In the study of Capsi et al. [<xref ref-type="bibr" rid="B19">19</xref>], ADHD subjects with the valval genotype had more symptoms of conduct disorder, were more aggressive, and were more likely to be convicted of criminal offenses compared with methionine carriers. Our present study also suggested a role for the Val variant in ADHD boys comorbid with ODD. ODD and CD seemed to be strongly and developmentally related [<xref ref-type="bibr" rid="B46">46</xref>]. Studies suggested that the onset of ODD symptoms may be a possible first step toward a life course characterized by the emergence of more serious antisocial and violent acts for some children [<xref ref-type="bibr" rid="B47">47</xref>,<xref ref-type="bibr" rid="B48">48</xref>]. In a genetic linkage study, Jain et al. [<xref ref-type="bibr" rid="B49">49</xref>] found that incorporating ODD and CD into the definition of affected increased evidence for linkage and implicated new chromosomal regions when compared to analyses examining the broader ADHD phenotype.</p><p>We found no evidence of association between the MAOA-uVNTR variant and ADHD with comorbid ODD or the ADHD-IA subtype in contrast with previous studies, in which the short variant was found to be associated with impulsivity, aggression, and ADHD with concurrent conduct disorder [<xref ref-type="bibr" rid="B50">50</xref>,<xref ref-type="bibr" rid="B51">51</xref>].</p><p>There were several limitations to this study that bear comment and suggest future directions. First, the major limitation of the study is the small number of individuals with the subtypes of ADHD. Our results, although nominally significant, were not significant after correcting for multiple comparisons. Larger samples, closer to 1000 are needed for more definitive results [<xref ref-type="bibr" rid="B52">52</xref>,<xref ref-type="bibr" rid="B53">53</xref>]. Second, we focused the study only in male ADHD subjects considering gender differences, as our previous evidence for a sexually dimorphic transmission of COMT Val158Met and MAOA-uVNTR alleles to individuals with ADHD could be a chance finding. Third, we performed the analyses in the ADHD patients without comparing healthy controls, which limits the generalization of these results. Finally, ADHD or related disorders might be accounted for by both genetic and environmental factors such as maternal prenatal smoking or drinking suggested by previous studies [<xref ref-type="bibr" rid="B54">54</xref>,<xref ref-type="bibr" rid="B55">55</xref>].</p></sec><sec><title>Conclusion</title><p>In summary, our study of attention deficit hyperactivity disorder comorbid oppositional defiant disorder and its predominately inattentive type highlights the potential etiologic role of COMT in a Chinese sample. But we failed to observe an interaction between COMT and MAOA, which suggests that epistasis between COMT and MAOA does not influence the phenotype of ADHD-IA with comorbid ODD in a clinical sample of Chinese male subjects. To confirm our findings further studies with a larger number of subjects and healthy controls are needed.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>QJQ and JL contributed equally to this work, they recruited the subjects, made consensus clinical diagnoses, analyzed the data and drafted the manuscript. YFW designed the study and assisted with proof-reading of the manuscript. LY and LLG also recruited the subjects and provided the data necessary for the analysis. SVF revised manuscript critically and assisted with proof-reading of the manuscript. All authors have read and given final approval of the final manuscript.</p></sec></body><back><ack><sec><title>Acknowledgements</title><p>The authors are grateful to the anonymous reviewer for the constructive comments which significantly improved the manuscript.</p><p>This work was supported in part by grants from the National Natural Sciences Foundation of China 30770774, the Commonweal Sciences Foundation from Ministry of Health of China 200802073, and the National Foundation from Ministry of Science and Technology of China 2007BAI17B03.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="book"><person-group person-group-type="author"><collab>American Psychiatric Association</collab></person-group><article-title>Diagnostic and statistical manual of mental disorders</article-title><source>(DSM-IV)</source><year>1994</year><edition>4</edition><publisher-name>Washington, DC: American Psychiatric Association</publisher-name></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Abikoff</surname><given-names>H</given-names></name><name><surname>Klein</surname><given-names>RG</given-names></name></person-group><article-title>Attention-deficit hyperactivity and conduct disorder: comorbidity and implications for treatment</article-title><source>J Consult Chin Psychol</source><year>1992</year><volume>60</volume><fpage>881</fpage><lpage>892</lpage></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>YF</given-names></name><name><surname>Qian</surname><given-names>QJ</given-names></name><name><surname>Biederman</surname><given-names>J</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name></person-group><article-title>DSM-IV subtypes of ADHD in a Chinese outpatient sample</article-title><source>J Am Acad Child Adolesc Psychiatry</source><year>2004</year><volume>43</volume><fpage>248</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">15076256</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nigg</surname><given-names>JT</given-names></name><name><surname>Willcutt</surname><given-names>EG</given-names></name><name><surname>Doyle</surname><given-names>AE</given-names></name><name><surname>Sonuga-Barke</surname><given-names>EJ</given-names></name></person-group><article-title>Causal Heterogeneity in Attention-Deficit/Hyperactivity Disorder: Do We Need Neuropsychologically Impaired Subtypes?</article-title><source>Biol Psychiatry</source><year>2005</year><volume>57</volume><fpage>1224</fpage><lpage>1230</lpage><pub-id pub-id-type="pmid">15949992</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Todd</surname><given-names>RD</given-names></name><name><surname>Rasmussen</surname><given-names>ER</given-names></name><name><surname>Neuman</surname><given-names>RJ</given-names></name><name><surname>Reich</surname><given-names>W</given-names></name><name><surname>Hudziak</surname><given-names>JJ</given-names></name><name><surname>Bucholz</surname><given-names>KK</given-names></name><name><surname>Madden</surname><given-names>PA</given-names></name><name><surname>Heath</surname><given-names>A</given-names></name></person-group><article-title>Familiality and heritability of subtypes of attention deficit hyperactivity disorder in a population sample of adolescent female twins</article-title><source>Am J Psychiatry</source><year>2001</year><volume>158</volume><fpage>1891</fpage><lpage>1898</lpage><pub-id pub-id-type="pmid">11691697</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>ER</given-names></name><name><surname>Neuman</surname><given-names>RJ</given-names></name><name><surname>Heath</surname><given-names>AC</given-names></name><name><surname>Levy</surname><given-names>F</given-names></name><name><surname>Hay</surname><given-names>DA</given-names></name><name><surname>Todd</surname><given-names>RD</given-names></name></person-group><article-title>Familial clustering of latent class and DSM-IV defined attention-deficit/hyperactivity disorder (ADHD) subtypes</article-title><source>J Child Psychol Psychiatry</source><year>2004</year><volume>45</volume><fpage>589</fpage><lpage>598</lpage><pub-id pub-id-type="pmid">15055377</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Faraone</surname><given-names>SV</given-names></name><name><surname>Perlis</surname><given-names>RH</given-names></name><name><surname>Doyle</surname><given-names>AE</given-names></name><name><surname>Smoller</surname><given-names>JW</given-names></name><name><surname>Goralnick</surname><given-names>JJ</given-names></name><name><surname>Holmgren</surname><given-names>MA</given-names></name><name><surname>Sklar</surname><given-names>P</given-names></name></person-group><article-title>Molecular genetics of attention-deficit/hyperactivity disorder</article-title><source>Biol Psychiatry</source><year>2005</year><volume>57</volume><fpage>1313</fpage><lpage>1323</lpage><pub-id pub-id-type="pmid">15950004</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neuman</surname><given-names>R</given-names></name><name><surname>Todd</surname><given-names>R</given-names></name><name><surname>Heath</surname><given-names>A</given-names></name><name><surname>Reich</surname><given-names>W</given-names></name><name><surname>Hudziak</surname><given-names>J</given-names></name><name><surname>Bucholz</surname><given-names>K</given-names></name><name><surname>Madden</surname><given-names>P</given-names></name><name><surname>Begleiter</surname><given-names>H</given-names></name><name><surname>Porjesz</surname><given-names>B</given-names></name><name><surname>Kuperman</surname><given-names>S</given-names></name><name><surname>Hesselbrock</surname><given-names>V</given-names></name><name><surname>Reich</surname><given-names>T</given-names></name></person-group><article-title>Evaluation of ADHD typology in three contrasting samples: A latent class approach</article-title><source>J Am Acad Child Adolesc Psychiatry</source><year>1999</year><volume>38</volume><fpage>25</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">9893413</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Glatt</surname><given-names>S</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name></person-group><article-title>Family-based and Case-control Association Studies of Catechol-O-Methyltransferase in Attention Deficit Hyperactivity Disorder Suggest Genetic Sexual Dimorphism</article-title><source>Am J Med Genet</source><year>2003</year><volume>118B</volume><fpage>103</fpage><lpage>109</lpage></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name></person-group><article-title>Serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder in Chinese Han subjects</article-title><source>Am J Med Genet</source><year>2005</year><volume>132</volume><fpage>59</fpage><lpage>63</lpage></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Faraone</surname><given-names>SV</given-names></name></person-group><article-title>Association between polymorphisms in serotonin 2C receptor gene and attention-deficit/hyperactivity disorder in Han Chinese subjects</article-title><source>Neurosci Lett</source><year>2006</year><volume>407</volume><fpage>107</fpage><lpage>111</lpage><pub-id pub-id-type="pmid">16959425</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nadder</surname><given-names>TS</given-names></name><name><surname>Rutter</surname><given-names>M</given-names></name><name><surname>Silberg</surname><given-names>JL</given-names></name><name><surname>Maes</surname><given-names>HH</given-names></name><name><surname>Eaves</surname><given-names>LJ</given-names></name></person-group><article-title>Genetic effects on the variation and covariation of attention deficit-hyperactivity disorder (ADHD) and oppositional-defiant disorder/conduct disorder (Odd/CD) symptomatologies across informant and occasion of measurement</article-title><source>Psychol Med</source><year>2002</year><volume>32</volume><fpage>39</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">11883729</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dick</surname><given-names>DM</given-names></name><name><surname>Viken</surname><given-names>RJ</given-names></name><name><surname>Kaprio</surname><given-names>J</given-names></name><name><surname>Pulkkinen</surname><given-names>L</given-names></name><name><surname>Rose</surname><given-names>RJ</given-names></name></person-group><article-title>Understanding the covariation among childhood externalizing symptoms: Genetic and environmental influences on conduct disorder, attention deficit hyperactivity disorder, and oppositional defiant disorder symptoms</article-title><source>J Abnorm Child Psychol</source><year>2005</year><volume>33</volume><fpage>219</fpage><lpage>229</lpage><pub-id pub-id-type="pmid">15839499</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lachman</surname><given-names>HM</given-names></name><name><surname>Papolos</surname><given-names>DF</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>YM</given-names></name><name><surname>Szumlanski</surname><given-names>CL</given-names></name><name><surname>Weinshilboum</surname><given-names>RM</given-names></name></person-group><article-title>Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders</article-title><source>Pharmacogenetics</source><year>1996</year><volume>6</volume><fpage>243</fpage><lpage>250</lpage><pub-id pub-id-type="pmid">8807664</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Lipska</surname><given-names>BK</given-names></name><name><surname>Halim</surname><given-names>N</given-names></name><name><surname>Ma</surname><given-names>QD</given-names></name><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Melhem</surname><given-names>S</given-names></name><name><surname>Kolachana</surname><given-names>BS</given-names></name><name><surname>Hyde</surname><given-names>TM</given-names></name><name><surname>Herman</surname><given-names>MM</given-names></name><name><surname>Apud</surname><given-names>J</given-names></name><name><surname>Egan</surname><given-names>MF</given-names></name><name><surname>Kleinman</surname><given-names>JE</given-names></name><name><surname>Weinberger</surname><given-names>DR</given-names></name></person-group><article-title>Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain</article-title><source>Am J Hum Genet</source><year>2004</year><volume>75</volume><fpage>807</fpage><lpage>821</lpage><pub-id pub-id-type="pmid">15457404</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gogos</surname><given-names>JA</given-names></name><name><surname>Morgan</surname><given-names>M</given-names></name><name><surname>Luine</surname><given-names>V</given-names></name><name><surname>Santha</surname><given-names>M</given-names></name><name><surname>Ogawa</surname><given-names>S</given-names></name><name><surname>Pfaff</surname><given-names>D</given-names></name><name><surname>Karayiorgou</surname><given-names>M</given-names></name></person-group><article-title>Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior</article-title><source>Proc Natl Acad Sci USA</source><year>1998</year><volume>95</volume><fpage>9991</fpage><lpage>9996</lpage><pub-id pub-id-type="pmid">9707588</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barnett</surname><given-names>JH</given-names></name><name><surname>Heron</surname><given-names>J</given-names></name><name><surname>Ring</surname><given-names>SM</given-names></name><name><surname>Golding</surname><given-names>J</given-names></name><name><surname>Goldman</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Jones</surname><given-names>PB</given-names></name></person-group><article-title>Gender-specific effects of the catechol-O-methyltransferase Val108/158Met polymorphism on cognitive function in children</article-title><source>Am J Psychiatry</source><year>2007</year><volume>164</volume><fpage>142</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">17202556</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thapar</surname><given-names>A</given-names></name><name><surname>Langley</surname><given-names>K</given-names></name><name><surname>Fowler</surname><given-names>T</given-names></name><name><surname>Rice</surname><given-names>F</given-names></name><name><surname>Turic</surname><given-names>D</given-names></name><name><surname>Whittinger</surname><given-names>N</given-names></name><name><surname>Aggleton</surname><given-names>J</given-names></name><name><surname>Bree</surname><given-names>M Van den</given-names></name><name><surname>Owen</surname><given-names>M</given-names></name><name><surname>O'Donovan</surname><given-names>M</given-names></name></person-group><article-title>Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder</article-title><source>Arch Gen Psychiatry</source><year>2005</year><volume>62</volume><fpage>1275</fpage><lpage>1278</lpage><pub-id pub-id-type="pmid">16275815</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caspi</surname><given-names>A</given-names></name><name><surname>Langley</surname><given-names>K</given-names></name><name><surname>Milne</surname><given-names>B</given-names></name><name><surname>Moffitt</surname><given-names>TE</given-names></name><name><surname>O'Donovan</surname><given-names>M</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name><name><surname>Polo Tomas</surname><given-names>M</given-names></name><name><surname>Poulton</surname><given-names>R</given-names></name><name><surname>Rutter</surname><given-names>M</given-names></name><name><surname>Taylor</surname><given-names>A</given-names></name><name><surname>Williams</surname><given-names>B</given-names></name><name><surname>Thapar</surname><given-names>A</given-names></name></person-group><article-title>A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder</article-title><source>Arch Gen Psychiatry</source><year>2008</year><volume>65</volume><fpage>203</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">18250258</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sengupta</surname><given-names>SM</given-names></name><name><surname>Grizenko</surname><given-names>N</given-names></name><name><surname>Schmitz</surname><given-names>N</given-names></name><name><surname>Schwartz</surname><given-names>G</given-names></name><name><surname>Ben Amor</surname><given-names>L</given-names></name><name><surname>Bellingham</surname><given-names>J</given-names></name><name><surname>de Guzman</surname><given-names>R</given-names></name><name><surname>Polotskaia</surname><given-names>A</given-names></name><name><surname>Ter Stepanian</surname><given-names>M</given-names></name><name><surname>Thakur</surname><given-names>G</given-names></name><name><surname>Joober</surname><given-names>R</given-names></name></person-group><article-title>COMT Val108/158Met gene variant, birth weight, and conduct disorder in children with ADHD</article-title><source>J Am Acad Child Adolesc Psychiatry</source><year>2006</year><volume>45</volume><fpage>1363</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17075359</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sabol</surname><given-names>SZ</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name><name><surname>Hamer</surname><given-names>D</given-names></name></person-group><article-title>A functional polymorphism in the monoamine oxidase A gene promoter</article-title><source>Hum Genet</source><year>1998</year><volume>103</volume><fpage>273</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">9799080</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deckert</surname><given-names>J</given-names></name><name><surname>Catalano</surname><given-names>M</given-names></name><name><surname>Syagailo</surname><given-names>YV</given-names></name><name><surname>Bosi</surname><given-names>M</given-names></name><name><surname>Okladnova</surname><given-names>O</given-names></name><name><surname>DiBella</surname><given-names>D</given-names></name><name><surname>Noethen</surname><given-names>MM</given-names></name><name><surname>Maffei</surname><given-names>P</given-names></name><name><surname>Franke</surname><given-names>P</given-names></name><name><surname>Fritze</surname><given-names>J</given-names></name><name><surname>Maier</surname><given-names>W</given-names></name><name><surname>Propping</surname><given-names>P</given-names></name><name><surname>Beckmann</surname><given-names>H</given-names></name><name><surname>Bellodi</surname><given-names>L</given-names></name><name><surname>Lesch</surname><given-names>KP</given-names></name></person-group><article-title>Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder</article-title><source>Hum Mol Genet</source><year>1999</year><volume>8</volume><fpage>621</fpage><lpage>624</lpage><pub-id pub-id-type="pmid">10072430</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cases</surname><given-names>O</given-names></name><name><surname>Seif</surname><given-names>I</given-names></name><name><surname>Grimsby</surname><given-names>J</given-names></name><name><surname>Gaspar</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>K</given-names></name><name><surname>Pournin</surname><given-names>S</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>U</given-names></name><name><surname>Aguet</surname><given-names>M</given-names></name><name><surname>Babinet</surname><given-names>C</given-names></name><name><surname>Shih</surname><given-names>JC</given-names></name><etal></etal></person-group><article-title>Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA</article-title><source>Science</source><year>1995</year><volume>268</volume><fpage>1763</fpage><lpage>1766</lpage><pub-id pub-id-type="pmid">7792602</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>Lachman</surname><given-names>HM</given-names></name><name><surname>Diaz</surname><given-names>L</given-names></name><name><surname>Hallikainen</surname><given-names>T</given-names></name><name><surname>Kauhanen</surname><given-names>J</given-names></name><name><surname>Salonen</surname><given-names>JT</given-names></name><name><surname>Ryyn&#x000e4;nen</surname><given-names>OP</given-names></name><name><surname>Karvonen</surname><given-names>MK</given-names></name><name><surname>Syv&#x000e4;lahti</surname><given-names>E</given-names></name><name><surname>Pohjalainen</surname><given-names>T</given-names></name><name><surname>Hietala</surname><given-names>J</given-names></name><name><surname>Tiihonen</surname><given-names>J</given-names></name></person-group><article-title>Analysis of monoamine oxidase A (MAOA) promoter polymorphism in Finnish male alcoholics</article-title><source>Psychiatry Res</source><year>2002</year><volume>109</volume><fpage>113</fpage><lpage>119</lpage><pub-id pub-id-type="pmid">11927135</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Caspi</surname><given-names>A</given-names></name><name><surname>McClay</surname><given-names>J</given-names></name><name><surname>Moffitt</surname><given-names>TE</given-names></name><name><surname>Mill</surname><given-names>J</given-names></name><name><surname>Martin</surname><given-names>J</given-names></name><name><surname>Craig</surname><given-names>IW</given-names></name><name><surname>Taylor</surname><given-names>A</given-names></name><name><surname>Poulton</surname><given-names>R</given-names></name></person-group><article-title>Role of genotype in the cycle of violence in maltreated children</article-title><source>Science</source><year>2002</year><volume>297</volume><fpage>851</fpage><lpage>854</lpage><pub-id pub-id-type="pmid">12161658</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>YY</given-names></name><name><surname>Cate</surname><given-names>SP</given-names></name><name><surname>Battistuzzi</surname><given-names>C</given-names></name><name><surname>Oquendo</surname><given-names>MA</given-names></name><name><surname>Brent</surname><given-names>D</given-names></name><name><surname>Mann</surname><given-names>JJ</given-names></name></person-group><article-title>An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences</article-title><source>Neuropsychopharmacology</source><year>2004</year><volume>29</volume><fpage>1498</fpage><lpage>1505</lpage><pub-id pub-id-type="pmid">15150530</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manor</surname><given-names>I</given-names></name><name><surname>Tyano</surname><given-names>S</given-names></name><name><surname>Mel</surname><given-names>E</given-names></name><name><surname>Eisenberg</surname><given-names>J</given-names></name><name><surname>Bachner-Melman</surname><given-names>R</given-names></name><name><surname>Kotler</surname><given-names>M</given-names></name><name><surname>Ebstein</surname><given-names>RP</given-names></name></person-group><article-title>Family-based and association studies of monoamine oxidase A and attention deficit hyperactivity disorder (ADHD): Preferential transmission of the long promoter-region repeat and its association with impaired performance on a continuous performance test (TOVA)</article-title><source>Mol Psychiatry</source><year>2002</year><volume>7</volume><fpage>626</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">12140786</pub-id></citation></ref><ref id="B28"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>YX</given-names></name><name><surname>Cai</surname><given-names>TS</given-names></name></person-group><source>Manual of Wechsler Intelligence Scale for Children, Chinese revision (C-WISC)</source><year>1993</year><publisher-name>Changsha, China: Hunan Map Press</publisher-name></citation></ref><ref id="B29"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Barkley</surname><given-names>RA</given-names></name></person-group><source>Attention-deficit hyperactivity disorder: A clinical workbook</source><year>1998</year><edition>2</edition><publisher-name>New York: Guilford</publisher-name><fpage>39</fpage><lpage>55</lpage></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jeffery</surname><given-names>DR</given-names></name><name><surname>Roth</surname><given-names>JA</given-names></name></person-group><article-title>Characterization of membrane-bound and soluble catechol-O-methyltransferase from human frontal cortex</article-title><source>J Neurochem</source><year>1984</year><volume>42</volume><fpage>826</fpage><lpage>832</lpage><pub-id pub-id-type="pmid">6693904</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tenhunen</surname><given-names>J</given-names></name><name><surname>Salminen</surname><given-names>M</given-names></name><name><surname>Lundstrom</surname><given-names>K</given-names></name><name><surname>Kiviluoto</surname><given-names>T</given-names></name><name><surname>Savolainen</surname><given-names>R</given-names></name><name><surname>Ulmanen</surname><given-names>I</given-names></name></person-group><article-title>Genomic organization of the human catechol-Omethyltransferase gene and its expression from two distinct promoters</article-title><source>Eur J Biochem</source><year>1994</year><volume>223</volume><fpage>1049</fpage><lpage>1059</lpage><pub-id pub-id-type="pmid">8055944</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huotari</surname><given-names>M</given-names></name><name><surname>Santha</surname><given-names>M</given-names></name><name><surname>Lucas</surname><given-names>LR</given-names></name><name><surname>Karayiorgou</surname><given-names>M</given-names></name><name><surname>Gogos</surname><given-names>JA</given-names></name><name><surname>M&#x000e4;nnist&#x000f6;</surname><given-names>PT</given-names></name></person-group><article-title>Effect of dopamine uptake inhibition on brain catecholamine levels and locomotion in catechol-O-methyltransferase-disrupted mice</article-title><source>J Pharmacol Exp Ther</source><year>2002</year><volume>303</volume><fpage>1309</fpage><lpage>1316</lpage><pub-id pub-id-type="pmid">12438556</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Giros</surname><given-names>B</given-names></name><name><surname>Jaber</surname><given-names>M</given-names></name><name><surname>Jones</surname><given-names>SR</given-names></name><name><surname>Wightman</surname><given-names>RM</given-names></name><name><surname>Caron</surname><given-names>MG</given-names></name></person-group><article-title>Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter</article-title><source>Nature</source><year>1996</year><volume>379</volume><fpage>606</fpage><lpage>612</lpage><pub-id pub-id-type="pmid">8628395</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karoum</surname><given-names>F</given-names></name><name><surname>Chrapusta</surname><given-names>SJ</given-names></name><name><surname>Egan</surname><given-names>MF</given-names></name></person-group><article-title>3-Methoxytyramine is the major metabolite of released dopamine in the rat frontal cortex: reassessment of the effects of antipsychotics on the dynamics of dopamine release and metabolism in the frontal cortex, nucleus accumbens, and striatum by a simple two pool model</article-title><source>J Neurochem</source><year>1994</year><volume>63</volume><fpage>972</fpage><lpage>979</lpage><pub-id pub-id-type="pmid">7914228</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sesack</surname><given-names>SR</given-names></name><name><surname>Hawrylak</surname><given-names>VA</given-names></name><name><surname>Matus</surname><given-names>C</given-names></name><name><surname>Guido</surname><given-names>MA</given-names></name><name><surname>Levey</surname><given-names>AI</given-names></name></person-group><article-title>Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter</article-title><source>J Neurosci</source><year>1998</year><volume>18</volume><fpage>2697</fpage><lpage>2708</lpage><pub-id pub-id-type="pmid">9502827</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tunbridge</surname><given-names>EM</given-names></name><name><surname>Bannerman</surname><given-names>DM</given-names></name><name><surname>Sharp</surname><given-names>T</given-names></name><name><surname>Harrison</surname><given-names>PJ</given-names></name></person-group><article-title>Catechol-Omethyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>5331</fpage><lpage>5335</lpage><pub-id pub-id-type="pmid">15190105</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>DA</given-names></name><name><surname>Sesack</surname><given-names>SR</given-names></name><name><surname>Levey</surname><given-names>AI</given-names></name><name><surname>Rosenberg</surname><given-names>DR</given-names></name></person-group><article-title>Dopamine axons in primate prefrontal cortex: specificity of distribution, synaptic targets, and development</article-title><source>Adv Pharmacol</source><year>1998</year><volume>42</volume><fpage>703</fpage><lpage>706</lpage><pub-id pub-id-type="pmid">9327996</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldman-Rakic</surname><given-names>PS</given-names></name></person-group><article-title>The cortical dopamine system: role in memory and cognition</article-title><source>Adv Pharmacol</source><year>1998</year><volume>42</volume><fpage>707</fpage><lpage>711</lpage><pub-id pub-id-type="pmid">9327997</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Egan</surname><given-names>MF</given-names></name><name><surname>Goldberg</surname><given-names>TE</given-names></name><name><surname>Kolachana</surname><given-names>BS</given-names></name><name><surname>Callicott</surname><given-names>JH</given-names></name><name><surname>Mazzanti</surname><given-names>CM</given-names></name><name><surname>Straub</surname><given-names>RE</given-names></name><name><surname>Goldman</surname><given-names>D</given-names></name><name><surname>Weinberger</surname><given-names>DR</given-names></name></person-group><article-title>Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia</article-title><source>Proc Natl Acad Sci USA</source><year>2001</year><volume>98</volume><fpage>6917</fpage><lpage>6922</lpage><pub-id pub-id-type="pmid">11381111</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weinberger</surname><given-names>DR</given-names></name><name><surname>Egan</surname><given-names>MF</given-names></name><name><surname>Bertolino</surname><given-names>A</given-names></name><name><surname>Callicott</surname><given-names>JH</given-names></name><name><surname>Mattay</surname><given-names>VS</given-names></name><name><surname>Lipska</surname><given-names>BK</given-names></name><name><surname>Berman</surname><given-names>KF</given-names></name><name><surname>Goldberg</surname><given-names>TE</given-names></name></person-group><article-title>Prefrontal neurons and the genetics of schizophrenia</article-title><source>Biol Psychiatry</source><year>2001</year><volume>50</volume><fpage>825</fpage><lpage>844</lpage><pub-id pub-id-type="pmid">11743939</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>TE</given-names></name><name><surname>Egan</surname><given-names>MF</given-names></name><name><surname>Gscheidle</surname><given-names>T</given-names></name><name><surname>Coppola</surname><given-names>R</given-names></name><name><surname>Weickert</surname><given-names>T</given-names></name><name><surname>Kolachana</surname><given-names>BS</given-names></name><name><surname>Goldman</surname><given-names>D</given-names></name><name><surname>Weinberger</surname><given-names>DR</given-names></name></person-group><article-title>Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia</article-title><source>Arch Gen Psychiatry</source><year>2003</year><volume>60</volume><fpage>889</fpage><lpage>896</lpage><pub-id pub-id-type="pmid">12963670</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>M</given-names></name><name><surname>Weickert</surname><given-names>CS</given-names></name><name><surname>Beltaifa</surname><given-names>S</given-names></name><name><surname>Kolachana</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Hyde</surname><given-names>TM</given-names></name><name><surname>Herman</surname><given-names>MM</given-names></name><name><surname>Weinberger</surname><given-names>DR</given-names></name><name><surname>Kleinman</surname><given-names>JE</given-names></name></person-group><article-title>Catechol-O-methyltransferase COMT. mRNA expression in the dorsolateral prefrontal cortex of patients with schizophrenia</article-title><source>Neuropsychopharmacology</source><year>2003</year><volume>28</volume><fpage>1521</fpage><lpage>1530</lpage><pub-id pub-id-type="pmid">12799619</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Diamond</surname><given-names>A</given-names></name><name><surname>Briand</surname><given-names>L</given-names></name><name><surname>Fossella</surname><given-names>J</given-names></name><name><surname>Gehlbach</surname><given-names>L</given-names></name></person-group><article-title>Genetic and neurochemical modulation of prefrontal cognitive functions in children</article-title><source>Am J Psychiatry</source><year>2004</year><volume>161</volume><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">14702260</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bellgrove</surname><given-names>MA</given-names></name><name><surname>Domschke</surname><given-names>K</given-names></name><name><surname>Hawi</surname><given-names>Z</given-names></name><name><surname>Kirley</surname><given-names>A</given-names></name><name><surname>Mullins</surname><given-names>C</given-names></name><name><surname>Robertson</surname><given-names>IH</given-names></name><name><surname>Gill</surname><given-names>M</given-names></name></person-group><article-title>The methionine allele of the COMT polymorphism impairs prefrontal cognition in children and adolescents with ADHD</article-title><source>Exp Brain Res</source><year>2005</year><volume>163</volume><fpage>352</fpage><lpage>360</lpage><pub-id pub-id-type="pmid">15654584</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Raine</surname><given-names>A</given-names></name></person-group><article-title>The role of prefrontal deficits, low autonomic arousal, and early health factors in the development of antisocial and aggressive behavior in children</article-title><source>J Child Psychol Psychiatry</source><year>2002</year><volume>43</volume><fpage>417</fpage><lpage>434</lpage><pub-id pub-id-type="pmid">12030589</pub-id></citation></ref><ref id="B46"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Conner</surname><given-names>DF</given-names></name></person-group><source>Aggression and antisocial behavior in children and adolescents: research and treatment</source><year>2000</year><publisher-name>New York &#x00026; London: The Guilford Press</publisher-name><fpage>64</fpage><lpage>75</lpage></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>August</surname><given-names>GJ</given-names></name><name><surname>Realmuto</surname><given-names>GM</given-names></name><name><surname>Joyce</surname><given-names>T</given-names></name><name><surname>Hektner</surname><given-names>JM</given-names></name></person-group><article-title>Persistence and desistance of oppositional defiant disorder in a community sample of children with ADHD</article-title><source>J Am Acad Child Adolesc Psychiatry</source><year>1999</year><volume>38</volume><fpage>1262</fpage><lpage>1270</lpage><pub-id pub-id-type="pmid">10517059</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Loeber</surname><given-names>R</given-names></name></person-group><article-title>Development and risk factors of juvenile antisocial behavior and delinquency</article-title><source>Clinical Psychology Review</source><year>1990</year><volume>10</volume><fpage>1</fpage><lpage>41</lpage></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jain</surname><given-names>M</given-names></name><name><surname>Palacio</surname><given-names>LG</given-names></name><name><surname>Castellanos</surname><given-names>FX</given-names></name><name><surname>Palacio</surname><given-names>JD</given-names></name><name><surname>Pineda</surname><given-names>D</given-names></name><name><surname>Restrepo</surname><given-names>MI</given-names></name><name><surname>Mu&#x000f1;oz</surname><given-names>JF</given-names></name><name><surname>Lopera</surname><given-names>F</given-names></name><name><surname>Wallis</surname><given-names>D</given-names></name><name><surname>Berg</surname><given-names>K</given-names></name><name><surname>Bailey-Wilson</surname><given-names>JE</given-names></name><name><surname>Arcos-Burgos</surname><given-names>M</given-names></name><name><surname>Muenke</surname><given-names>M</given-names></name></person-group><article-title>Attention-Deficit/Hyperactivity Disorder and Comorbid Disruptive Behavior Disorders: Evidence of Pleiotropy and New Susceptibility Loci</article-title><source>Biol Psychiatry</source><year>2007</year><volume>61</volume><fpage>1329</fpage><lpage>1339</lpage><pub-id pub-id-type="pmid">16950213</pub-id></citation></ref><ref id="B50"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Manuck</surname><given-names>SB</given-names></name><name><surname>Flory</surname><given-names>JD</given-names></name><name><surname>Ferrell</surname><given-names>RE</given-names></name><name><surname>Mann</surname><given-names>JJ</given-names></name><name><surname>Muldoon</surname><given-names>MF</given-names></name></person-group><article-title>A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity</article-title><source>Psychiatry Res</source><year>2000</year><volume>95</volume><fpage>9</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">10904119</pub-id></citation></ref><ref id="B51"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lawson</surname><given-names>DC</given-names></name><name><surname>Turic</surname><given-names>D</given-names></name><name><surname>Langley</surname><given-names>K</given-names></name><name><surname>Pay</surname><given-names>HM</given-names></name><name><surname>Govan</surname><given-names>CF</given-names></name><name><surname>Norton</surname><given-names>N</given-names></name><name><surname>Hamshere</surname><given-names>ML</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name><name><surname>O'Donovan</surname><given-names>MC</given-names></name><name><surname>Thapar</surname><given-names>A</given-names></name></person-group><article-title>Association analysis of monoamine oxidase A and attention deficit hyperactivity disorder</article-title><source>Am J Med Genet</source><year>2003</year><volume>116</volume><fpage>84</fpage><lpage>89</lpage></citation></ref><ref id="B52"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>WY</given-names></name><name><surname>Barratt</surname><given-names>BJ</given-names></name><name><surname>Clayton</surname><given-names>DG</given-names></name><name><surname>Todd</surname><given-names>JA</given-names></name></person-group><article-title>Genome-wide association studies: theoretical and practical concerns</article-title><source>Nat Rev Genet</source><year>2005</year><volume>6</volume><fpage>109</fpage><lpage>118</lpage><pub-id pub-id-type="pmid">15716907</pub-id></citation></ref><ref id="B53"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Craddock</surname><given-names>N</given-names></name><name><surname>Owen</surname><given-names>MJ</given-names></name><name><surname>MC</surname><given-names>O'Donovan</given-names></name></person-group><article-title>The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons</article-title><source>Mol Psychiatry</source><year>2006</year><volume>11</volume><fpage>446</fpage><lpage>458</lpage><pub-id pub-id-type="pmid">16505837</pub-id></citation></ref><ref id="B54"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kahn</surname><given-names>R</given-names></name><name><surname>Khoury</surname><given-names>J</given-names></name><name><surname>Nichols</surname><given-names>WC</given-names></name><name><surname>Lanphnear</surname><given-names>B</given-names></name></person-group><article-title>Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive-impulsive, inattentive, and oppositional behaviors</article-title><source>J Pediatrics</source><year>2003</year><volume>143</volume><fpage>104</fpage><lpage>110</lpage></citation></ref><ref id="B55"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brookes</surname><given-names>KJ</given-names></name><name><surname>Mill</surname><given-names>J</given-names></name><name><surname>Guindalini</surname><given-names>C</given-names></name><name><surname>Curran</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Knight</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>CK</given-names></name><name><surname>Huang</surname><given-names>YS</given-names></name><name><surname>Sethna</surname><given-names>V</given-names></name><name><surname>Taylor</surname><given-names>E</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Breen</surname><given-names>G</given-names></name><name><surname>Asherson</surname><given-names>P</given-names></name></person-group><article-title>A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy</article-title><source>Arch Gene Psychiatry</source><year>2006</year><volume>63</volume><fpage>74</fpage><lpage>81</lpage></citation></ref></ref-list></back></article> 